We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.06B
AUM Growth
-$221M
Cap. Flow
-$22.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17

Top Buys

Rank Stock Value
1
AIR icon
AAR Corp
AIR
+$23.4M
2
RDNT icon
RadNet
RDNT
+$13.8M
3
IMGN
Immunogen Inc
IMGN
+$13.8M
4
CBAY
Cymabay Therapeutics
CBAY
+$13M
5
SVV icon
Savers
SVV
+$12.6M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$32.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$27.5M
3
PLNT icon
Planet Fitness
PLNT
+$27.5M
4
SMCI icon
Super Micro Computer
SMCI
+$17.1M
5
WOOF icon
Petco
WOOF
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.32%
2 Industrials 21.96%
3 Technology 19.12%
4 Consumer Discretionary 9.24%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTSI icon
26
MACOM Technology Solutions
MTSI
$20.4B
$23.2M 1.12%
284,444
-38,906
-12% -$2.88M
ATI icon
27
ATI
ATI
$25.4B
$23M 1.11%
558,505
+2,905
+0.5% +$129K
PLMR icon
28
Palomar
PLMR
$3.59B
$22.9M 1.11%
451,538
+2
+0% +$109
ONT
29
Onterris Inc
ONT
$756M
$22.7M 1.1%
777,221
+298,629
+62% +$11.3M
HRI icon
30
Herc Holdings
HRI
$4.99B
$22.3M 1.08%
187,789
-399
-0.2% -$52.1K
ATRC icon
31
AtriCure
ATRC
$1.77B
$21.9M 1.06%
498,972
+3
+0% +$146
BWIN
32
Baldwin Insurance Group
BWIN
$2.66B
$21.7M 1.05%
934,086
-221
-0% -$5.53K
NOG icon
33
Northern Oil and Gas
NOG
$2.31B
$21.5M 1.04%
535,190
-304,393
-36% -$12M
SKWD icon
34
Skyward Specialty Insurance
SKWD
$2.4B
$21M 1.02%
766,518
-498
-0.1% -$12.4K
PRVA icon
35
Privia Health
PRVA
$3.39B
$20.9M 1.01%
908,858
+51,944
+6% +$1.32M
MC icon
36
Moelis & Co
MC
$5.02B
$20.7M 1%
458,302
-443
-0.1% -$20.8K
EXPO icon
37
Exponent
EXPO
$3.05B
$20.7M 1%
241,440
-40,203
-14% -$3.64M
RMBS icon
38
Rambus
RMBS
$11B
$20.3M 0.98%
364,279
+75,033
+26% +$4.26M
TTI icon
39
TETRA Technologies
TTI
$1.37B
$20.3M 0.98%
3,182,502
-230,317
-7% -$1.19M
ITCI
40
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$19.9M 0.96%
381,740
+46,574
+14% +$2.71M
TMCI icon
41
Treace Medical Concepts
TMCI
$279M
$19.3M 0.94%
1,473,281
+107,143
+8% +$1.96M
CELH icon
42
Celsius Holdings
CELH
$7.41B
$19.1M 0.93%
334,302
-110,514
-25% -$6.21M
BBIO icon
43
BridgeBio Pharma
BBIO
$15.9B
$18.3M 0.89%
694,000
+214,875
+45% +$6.1M
PDFS icon
44
PDF Solutions
PDFS
$2.14B
$18.2M 0.88%
560,920
+29,363
+6% +$1.12M
REPL icon
45
Replimune Group
REPL
$859M
$18M 0.87%
1,052,524
-33,763
-3% -$663K
HLI icon
46
Houlihan Lokey
HLI
$9.67B
$17.9M 0.87%
166,969
-15,134
-8% -$1.56M
CHX
47
DELISTED
ChampionX
CHX
$17.8M 0.86%
500,445
-309,375
-38% -$11M
RARE icon
48
Ultragenyx Pharmaceutical
RARE
$2.88B
$17.5M 0.85%
491,689
-60,447
-11% -$2.39M
INDI icon
49
indie Semiconductor
INDI
$809M
$17.4M 0.84%
2,768,582
+672,284
+32% +$5.2M
VAL icon
50
Valaris
VAL
$5.3B
$17.1M 0.83%
227,985
+1
+0% +$73
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Emerald Advisers held 249 positions worth $2.06B, down 9.7% from $2.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2023 filing shows 38 new, 87 increased, 99 reduced and 17 closed positions. Its largest new stake was RadNet: 443,538 shares worth $12.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Emerald Advisers's largest Q3 2023 buy was RadNet: 443,538 shares worth $12.5M.
  • Emerald Advisers added most to AAR Corp in Q3 2023, an estimated $23.4M increase.
  • Emerald Advisers's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $17.1M.
  • Emerald Advisers fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $32.3M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.06B portfolio in Q3 2023.
  • Emerald Advisers opened 38 new positions and closed 17 in Q3 2023.
  • Emerald Advisers's portfolio value fell 9.7% quarter-over-quarter to $2.06B.

Based on Emerald Advisers's 13F filing for Q3 2023, filed 26 Oct 2023.